{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T15:54:29Z","timestamp":1783007669942,"version":"3.54.5"},"reference-count":57,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.3892\/ijo.2016.3435","type":"journal-article","created":{"date-parts":[[2016,3,10]],"date-time":"2016-03-10T09:23:47Z","timestamp":1457601827000},"page":"2071-2078","source":"Crossref","is-referenced-by-count":22,"title":["MicroRNA analysis of breast ductal fluid in breast cancer patients"],"prefix":"10.3892","volume":"48","author":[{"given":"LUISA MATOS","family":"DO CANTO","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CATALIN","family":"MARIAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SHAWNA","family":"WILLEY","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MARY","family":"SIDAWY","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PATRICIA A.","family":"DA CUNHA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JANICE D.","family":"RONE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XIN","family":"LI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YURIY","family":"GUSEV","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BASSEM R.","family":"HADDAD","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2016,3,10]]},"reference":[{"key":"key20180107185316_b1-ijo-48-05-2071","volume-title":"Global Cancer Facts & Figures","author":"American Cancer Society","year":"2011","edition":"2nd edition"},{"key":"key20180107185316_b2-ijo-48-05-2071","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ceb.2009.03.002","article-title":"MicroRNAs and cancer - new paradigms in molecular oncology","volume":"21","author":"Negrini","year":"2009","journal-title":"Curr Opin Cell Biol"},{"key":"key20180107185316_b3-ijo-48-05-2071","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.7150\/thno.11543","article-title":"MicroRNAs: New biomarkers for diagnosis, prognosis, therapy prediction and therapeutic tools for breast cancer","volume":"5","author":"Bertoli","year":"2015","journal-title":"Theranostics"},{"key":"key20180107185316_b4-ijo-48-05-2071","first-page":"59","article-title":"Critical analysis of the potential for microRNA biomarkers in breast cancer management","volume":"7","author":"Graveel","year":"2015","journal-title":"Breast Cancer (Dove Med Press)"},{"key":"key20180107185316_b5-ijo-48-05-2071","doi-asserted-by":"crossref","first-page":"7065","DOI":"10.1158\/0008-5472.CAN-05-1783","article-title":"MicroRNA gene expression deregulation in human breast cancer","volume":"65","author":"Iorio","year":"2005","journal-title":"Cancer Res"},{"key":"key20180107185316_b6-ijo-48-05-2071","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1053\/j.seminoncol.2011.08.005","article-title":"MicroRNAs: Toward the clinic for breast cancer patients","volume":"38","author":"Ferracin","year":"2011","journal-title":"Semin Oncol"},{"key":"key20180107185316_b7-ijo-48-05-2071","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/tbj.12362","article-title":"Development of a novel approach for breast cancer prediction and early detection using minimally invasive procedures and molecular analysis: How cytomorphology became a breast cancer risk predictor","volume":"21","author":"Masood","year":"2015","journal-title":"Breast J"},{"key":"key20180107185316_b8-ijo-48-05-2071","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jprot.2015.01.011","article-title":"Proteomic profiling of nipple aspirate fluid (NAF): Exploring the complementarity of different peptide fractionation strategies","volume":"117","author":"Brunoro","year":"2015","journal-title":"J Proteomics"},{"key":"key20180107185316_b9-ijo-48-05-2071","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/dc.10257","article-title":"Immunocytochemical evaluation of HER-2\/neu on fine-needle aspirates from primary breast carcinomas","volume":"28","author":"Nizzoli","year":"2003","journal-title":"Diagn Cytopathol"},{"key":"key20180107185316_b10-ijo-48-05-2071","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1185\/03007995.2014.988209","article-title":"Proliferative epithelial disease identified in nipple aspirate fluid and risk of developing breast cancer: A systematic review","volume":"31","author":"Hornberger","year":"2015","journal-title":"Curr Med Res Opin"},{"key":"key20180107185316_b11-ijo-48-05-2071","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1021\/pr400924k","article-title":"Metabolomic characterization of nipple aspirate fluid by (1)H NMR spectroscopy and GC-MS","volume":"13","author":"Tredwell","year":"2014","journal-title":"J Proteome Res"},{"key":"key20180107185316_b12-ijo-48-05-2071","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.steroids.2014.08.002","article-title":"Methodological considerations in estrogen assays of breast fluid and breast tissue","volume":"99","author":"Chatterton","year":"2015","journal-title":"Steroids"},{"key":"key20180107185316_b13-ijo-48-05-2071","doi-asserted-by":"crossref","first-page":"890","DOI":"10.2144\/02334mt02","article-title":"Increased yield of total RNA from fine-needle aspirates for use in expression microarray analysis","volume":"33","author":"Dunmire","year":"2002","journal-title":"Biotechniques"},{"key":"key20180107185316_b14-ijo-48-05-2071","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/S0140-6736(00)04501-3","article-title":"Detection of breast cancer cells in ductal lavage fluid by methylation-specific PCR","volume":"357","author":"Evron","year":"2001","journal-title":"Lancet"},{"key":"key20180107185316_b15-ijo-48-05-2071","first-page":"794","article-title":"The feasibility of using fine needle aspiration from primary breast cancers for cDNA microarray analyses","volume":"8","author":"Assersohn","year":"2002","journal-title":"Clin Cancer Res"},{"key":"key20180107185316_b16-ijo-48-05-2071","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.repbio.2013.01.179","article-title":"Assessment of RNA in human breast tissue sampled by random periareolar fine needle aspiration and ductal lavage and processed as fixed or frozen specimens","volume":"13","author":"Phillips","year":"2013","journal-title":"Reprod Biol"},{"key":"key20180107185316_b17-ijo-48-05-2071","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4137\/BCBCR.S23577","article-title":"An improved breast epithelial sampling method for molecular profiling and biomarker analysis in women at risk for breast cancer","volume":"9","author":"Danforth","year":"2015","journal-title":"Breast Cancer (Auckl)"},{"key":"key20180107185316_b18-ijo-48-05-2071","doi-asserted-by":"crossref","first-page":"827viii","DOI":"10.1016\/j.cll.2005.08.014","article-title":"Cytomorphology as a risk predictor: experience with fine needle aspiration biopsy, nipple fluid aspiration, and ductal lavage","volume":"25","author":"Masood","year":"2005","journal-title":"Clin Lab Med"},{"key":"key20180107185316_b19-ijo-48-05-2071","doi-asserted-by":"crossref","first-page":"374","DOI":"10.2144\/03342mt01","article-title":"TM4: A free, open-source system for microarray data management and analysis","volume":"34","author":"Saeed","year":"2003","journal-title":"Biotechniques"},{"issue":"W1","key":"key20180107185316_b20-ijo-48-05-2071","doi-asserted-by":"crossref","first-page":"W498","DOI":"10.1093\/nar\/gks494","article-title":"DIANA miRPath v2.0: Investigating the combinatorial effect of microRNAs in pathways","volume":"40","author":"Vlachos","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"key20180107185316_b21-ijo-48-05-2071","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1158\/0008-5472.CAN-12-2162","article-title":"Prooncogenic factors miR-23b and miR-27b are regulated by Her2\/Neu, EGF, and TNF-\u03b1 in breast cancer","volume":"73","author":"Jin","year":"2013","journal-title":"Cancer Res"},{"key":"key20180107185316_b22-ijo-48-05-2071","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/carcin\/bgu202","article-title":"The role of miR-200a in mammalian epithelial cell transformation","volume":"36","author":"Becker","year":"2015","journal-title":"Carcinogenesis"},{"key":"key20180107185316_b23-ijo-48-05-2071","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.yexmp.2013.12.004","article-title":"miR-126 in human cancers: Clinical roles and current perspectives","volume":"96","author":"Ebrahimi","year":"2014","journal-title":"Exp Mol Pathol"},{"key":"key20180107185316_b24-ijo-48-05-2071","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.biopha.2015.07.027","article-title":"MiR-548-3p functions as an anti-oncogenic regulator in breast cancer","volume":"75","author":"Shi","year":"2015","journal-title":"Biomed Pharmacother"},{"key":"key20180107185316_b25-ijo-48-05-2071","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/cdd.2015.116","article-title":"Downregulation of microRNA-362-3p and microRNA-329 promotes tumor progression in human breast cancer","volume":"23","author":"Kang","year":"2016","journal-title":"Cell Death Differ"},{"key":"key20180107185316_b26-ijo-48-05-2071","doi-asserted-by":"crossref","first-page":"21888","DOI":"10.1074\/jbc.M114.582866","article-title":"The microRNA-23b\/27b\/24 cluster promotes breast cancer lung metastasis by targeting metastasis-suppressive gene prosaposin","volume":"289","author":"Ell","year":"2014","journal-title":"J Biol Chem"},{"key":"key20180107185316_b27-ijo-48-05-2071","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/ncb2690","article-title":"miR-126 and miR-126* repress recruitment of mesenchymal stem cells and inflammatory monocytes to inhibit breast cancer metastasis","volume":"15","author":"Zhang","year":"2013","journal-title":"Nat Cell Biol"},{"key":"key20180107185316_b28-ijo-48-05-2071","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1172\/JCI64946","article-title":"TGF-\u03b2 upregulates miR-181a expression to promote breast cancer metastasis","volume":"123","author":"Taylor","year":"2013","journal-title":"J Clin Invest"},{"key":"key20180107185316_b29-ijo-48-05-2071","doi-asserted-by":"crossref","first-page":"e109508","DOI":"10.1371\/journal.pone.0109508","article-title":"Overexpression of microRNA-200c predicts poor outcome in patients with PR-negative breast cancer","volume":"9","author":"Tuomarila","year":"2014","journal-title":"PLoS One"},{"key":"key20180107185316_b30-ijo-48-05-2071","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s10549-015-3460-x","article-title":"Tumor tissue microRNA expression in association with triple-negative breast cancer outcomes","volume":"152","author":"Liu","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"key20180107185316_b31-ijo-48-05-2071","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1016\/j.ejca.2013.07.145","article-title":"Increased expression of miR-126 and miR-10a predict prolonged relapse-free time of primary oestrogen receptor-positive breast cancer following tamoxifen treatment","volume":"49","author":"Hoppe","year":"2013","journal-title":"Eur J Cancer"},{"key":"key20180107185316_b32-ijo-48-05-2071","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s12032-014-0347-3","article-title":"MiR-363 sensitizes cisplatin-induced apoptosis targeting in Mcl-1 in breast cancer","volume":"31","author":"Zhang","year":"2014","journal-title":"Med Oncol"},{"key":"key20180107185316_b33-ijo-48-05-2071","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1186\/s13058-014-0435-5","article-title":"miR-638 mediated regulation of BRCA1 affects DNA repair and sensitivity to UV and cisplatin in triple-negative breast cancer","volume":"16","author":"Tan","year":"2014","journal-title":"Breast Cancer Res"},{"key":"key20180107185316_b34-ijo-48-05-2071","doi-asserted-by":"crossref","first-page":"10973","DOI":"10.1074\/jbc.M112.434340","article-title":"The overexpression of hypomethylated miR-663 induces chemotherapy resistance in human breast cancer cells by targeting heparin sulfate proteoglycan 2 (HSPG2)","volume":"288","author":"Hu","year":"2013","journal-title":"J Biol Chem"},{"key":"key20180107185316_b35-ijo-48-05-2071","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.cca.2012.02.016","article-title":"Analysis of serum genome-wide microRNAs for breast cancer detection","volume":"413","author":"Wu","year":"2012","journal-title":"Clin Chim Acta"},{"key":"key20180107185316_b36-ijo-48-05-2071","doi-asserted-by":"crossref","first-page":"680","DOI":"10.3892\/ijmm.2012.1021","article-title":"Decreased serum miR-181a is a potential new tool for breast cancer screening","volume":"30","author":"Guo","year":"2012","journal-title":"Int J Mol Med"},{"key":"key20180107185316_b37-ijo-48-05-2071","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1158\/1078-0432.CCR-12-3401","article-title":"Identification of circulating microRNA signatures for breast cancer detection","volume":"19","author":"Chan","year":"2013","journal-title":"Clin Cancer Res"},{"key":"key20180107185316_b38-ijo-48-05-2071","doi-asserted-by":"crossref","first-page":"R42","DOI":"10.1186\/bcr3428","article-title":"Serum microRNA expression as an early marker for breast cancer risk in prospectively collected samples from the Sister Study cohort","volume":"15","author":"Godfrey","year":"2013","journal-title":"Breast Cancer Res"},{"key":"key20180107185316_b39-ijo-48-05-2071","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00432-012-1315-y","article-title":"Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer","volume":"139","author":"Si","year":"2013","journal-title":"J Cancer Res Clin Oncol"},{"key":"key20180107185316_b40-ijo-48-05-2071","doi-asserted-by":"crossref","first-page":"e101950","DOI":"10.1371\/journal.pone.0101950","article-title":"Alterations in circulating miRNA levels following early-stage estrogen receptor-positive breast cancer resection in post-menopausal women","volume":"9","author":"Kodahl","year":"2014","journal-title":"PLoS One"},{"key":"key20180107185316_b41-ijo-48-05-2071","doi-asserted-by":"crossref","first-page":"5972","DOI":"10.1158\/1078-0432.CCR-12-1407","article-title":"Circulating miRNAs as surrogate markers for circulating tumor cells and prognostic markers in metastatic breast cancer","volume":"18","author":"Madhavan","year":"2012","journal-title":"Clin Cancer Res"},{"key":"key20180107185316_b42-ijo-48-05-2071","doi-asserted-by":"crossref","first-page":"11371","DOI":"10.4238\/2015.September.25.4","article-title":"Expressional analysis of immune-related miRNAs in breast milk","volume":"14","author":"Na","year":"2015","journal-title":"Genet Mol Res"},{"key":"key20180107185316_b43-ijo-48-05-2071","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.gene.2013.11.035","article-title":"Upregulated microRNA-301a in breast cancer promotes tumor metastasis by targeting PTEN and activating Wnt\/\u03b2-catenin signaling","volume":"535","author":"Ma","year":"2014","journal-title":"Gene"},{"key":"key20180107185316_b44-ijo-48-05-2071","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1038\/onc.2011.571","article-title":"MicroRNA-520\/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-\u03baB and TGF-\u03b2 signaling pathways","volume":"31","author":"Keklikoglou","year":"2012","journal-title":"Oncogene"},{"key":"key20180107185316_b45-ijo-48-05-2071","doi-asserted-by":"crossref","first-page":"32737","DOI":"10.18632\/oncotarget.5355","article-title":"MicroRNA-99a inhibits tumor aggressive phenotypes through regulating HOXA1 in breast cancer cells","volume":"6","author":"Wang","year":"2015","journal-title":"Oncotarget"},{"key":"key20180107185316_b46-ijo-48-05-2071","doi-asserted-by":"crossref","first-page":"7413","DOI":"10.1073\/pnas.1304977110","article-title":"Prognostic microRNA\/mRNA signature from the integrated analysis of patients with invasive breast cancer","volume":"110","author":"Volinia","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107185316_b47-ijo-48-05-2071","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s12032-014-0283-2","article-title":"Upregulation of miR-301a correlates with poor prognosis in triple-negative breast cancer","volume":"31","author":"Yu","year":"2014","journal-title":"Med Oncol"},{"key":"key20180107185316_b48-ijo-48-05-2071","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1158\/0008-5472.CAN-14-2341","article-title":"Cytidine deaminase axis modulated by miR-484 differentially regulates cell proliferation and chemoresistance in breast cancer","volume":"75","author":"Ye","year":"2015","journal-title":"Cancer Res"},{"key":"key20180107185316_b49-ijo-48-05-2071","doi-asserted-by":"crossref","first-page":"e0133643","DOI":"10.1371\/journal.pone.0133643","article-title":"Reduced let-7a is associated with chemoresistance in primary breast cancer","volume":"10","author":"Wu","year":"2015","journal-title":"PLoS One"},{"key":"key20180107185316_b50-ijo-48-05-2071","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.biopha.2014.09.011","article-title":"miRNA expression patterns in chemoresistant breast cancer tissues","volume":"68","author":"Lv","year":"2014","journal-title":"Biomed Pharmacother"},{"key":"key20180107185316_b51-ijo-48-05-2071","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.3892\/or.2015.4173","article-title":"MicroRNA-144 affects radiotherapy sensitivity by promoting proliferation, migration and invasion of breast cancer cells","volume":"34","author":"Yu","year":"2015","journal-title":"Oncol Rep"},{"key":"key20180107185316_b52-ijo-48-05-2071","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/1471-2407-14-200","article-title":"MicroRNA-484 is more highly expressed in serum of early breast cancer patients compared to healthy volunteers","volume":"14","author":"Zearo","year":"2014","journal-title":"BMC Cancer"},{"key":"key20180107185316_b53-ijo-48-05-2071","doi-asserted-by":"crossref","first-page":"e110644","DOI":"10.1371\/journal.pone.0110644","article-title":"Circulating microRNAs as easyto-measure aging biomarkers in older breast cancer patients: Correlation with chronological age but not with fitness\/frailty status","volume":"9","author":"Hatse","year":"2014","journal-title":"PLoS One"},{"key":"key20180107185316_b54-ijo-48-05-2071","doi-asserted-by":"crossref","first-page":"e87032","DOI":"10.1371\/journal.pone.0087032","article-title":"Identification and validation of oncologic miRNA biomarkers for luminal A-like breast cancer","volume":"9","author":"McDermott","year":"2014","journal-title":"PLoS One"},{"key":"key20180107185316_b55-ijo-48-05-2071","first-page":"3969","article-title":"microRNA expression in prospectively collected blood as a potential biomarker of breast cancer risk in the BCFR","volume":"35","author":"Chang","year":"2015","journal-title":"Anticancer Res"},{"key":"key20180107185316_b56-ijo-48-05-2071","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.3892\/ijmm.2014.1677","article-title":"miRNA profiling reveals a potential role of milk stasis in breast carcinogenesis","volume":"33","author":"Gu","year":"2014","journal-title":"Int J Mol Med"},{"key":"key20180107185316_b57-ijo-48-05-2071","article-title":"The levels of human milk microRNAs and their association with maternal weight characteristics","author":"Xi","year":"2015","journal-title":"Eur J Clin Nutr"}],"container-title":["International Journal of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijo.2016.3435\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T18:32:23Z","timestamp":1748802743000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijo.2016.3435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,10]]},"references-count":57,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2016,3,10]]},"published-print":{"date-parts":[[2016,5]]}},"alternative-id":["10.3892\/ijo.2016.3435"],"URL":"https:\/\/doi.org\/10.3892\/ijo.2016.3435","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,10]]}}}